Physician profile
Calvin Matthews
NPI 1376616367
$3,968.79
in general payments reported to CMS, 2019-2025
11 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $92.83 · 2021: $77.37 · 2022: $733 · 2023: $1,407 · 2024: $1,268 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,112 · Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,111.51 |
| Food and Beverage | $793.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,436.29 | 2021-2025 | Twinfix, Titan Total Shoulder System, Aetos Shoulder System |
| Medacta USA, INC. | $1,182.27 | 2024 | |
| Nevro Corp. | $649.73 | 2022 | |
| Stryker Corporation | $261.99 | 2019-2025 | Variax |
| Integra Lifesciences Corporation | $152.71 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ferring Pharmaceuticals INC. | $90.00 | 2019-2022 | |
| Sanara Medtech INC. | $86.14 | 2024 | Celleraterx |
| Depuy Synthes Sales INC. | $59.16 | 2019-2025 | Orthovisc, Monovisc |
| Heraeus Medical, LLC. | $18.58 | 2023 | Palacos |
| Bioventus LLC | $17.83 | 2019 | |
| Heron Therapeutics, INC. | $14.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Calvin Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.